Table 2:

Acetylsalicylic acid use according to demographic and clinical characteristics

CharacteristicNo. (%) who used ASA*p value
Age group, yr< 0.001
 50–59462 (15.5)
 60–69917 (28.3)
Sex0.4
 Male1006 (22.4)
 Female373 (21.4)
Income0.02
 Low552 (23.4)
 Medium629 (21.4)
 High98 (19.6)
Education0.002
 Low457 (24.3)
 Medium414 (22.1)
 High494 (20.4)
Regular medical visits< 0.001
 Yes1157 (26.0)
 No222 (12.4)
Obesity< 0.001
 Yes610 (30.5)
 No742 (18.0)
Hypertension< 0.001
 Yes869 (34.6)
 No510 (13.7)
Diabetes< 0.001
 Yes478 (60.7)
 No901 (16.6)
Dyslipidemia
 Yes849 (35.7)
 No530 (13.7)
Smoking category< 0.001
 Active198 (17.0)
 Stopped676 (24.7)
 Never446 (21.7)
 Occasional47 (21.4)
  • Note: ASA = acetylsalicylic acid.

  • * ASA or other platelet aggregation inhibitor(s).

  • For difference in the proportion of ASA users between subgroups.